| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Saccomano Nicholas A is a President And CEO at OnKure Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $29K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | OKUR Onkure Therapeutics, Inc. | President And CEO | Sell | 86 | $4.16 | $357.46 | -1.2% | - | - | |
| Dec 22, 2025 | OKUR Onkure Therapeutics, Inc. | President And CEO | Sell | 87 | $2.97 | $258.19 | -1.2% | +34.5% | - | |
| Sep 22, 2025 | OKUR Onkure Therapeutics, Inc. | President And CEO | Sell | 88 | $2.62 | $230.87 | -2.4% | +13.4% | - | |
| Jun 23, 2025 | OKUR Onkure Therapeutics, Inc. | President And CEO | Sell | 88 | $2.38 | $209.81 | -2.4% | +8.3% | - | |
| Apr 7, 2025 | OKUR Onkure Therapeutics, Inc. | President And CEO | Sell | 874 | $2.94 | $2,569.52 | -10.0% | -22.7% | +38.8% |